Last month, I was a speaker at the Med Tech Monday Conference in Irvine CA. It was a great conference with speakers covering every aspect of the medical technology market – from product development to regulatory approval. I spoke about how to use licensing as a strategy to get your medical device technology into the commercial market. The presentation focused on seven key reasons why licensing is one of the best go-to-market strategies for the med-tech industry – especially for startups.
Licensing is a low risk and low-cost way to plant your flag internationally. It’s less expensive than launching joint ventures or wholly owned subsidiaries. Licensing is an especially good strategy if you’re a startup or small business with limited financial resources. Licensing offers a number of strategies for entering international markets. Which one you use depends on your IP and business goals.
For many startups, going all the way from IP development to market launch is often capital intensive. Many times funding is hard to get because of the high costs and risks involved. That’s where the licensing route is one of best strategies to use.
Increasing sales, especially to larger customers, doesn’t mean larger selling expenses. Recently a small environmental systems company licensed a larger company, giving it exclusive rights to sell its water pollution control and water treatment technology to their Fortune 50 customers. This licensing strategy expanded the company into a new sales […]
Don’t shortchange the time it takes to structure the right type of licensing agreement. If the agreement is riddled with holes, nothing is more draining in both time and money then having to litigate your way out of a licensing agreement. Your licensing agreement is a contract between you and […]